INS and Alzheimer disease: Thus, our results indicate that Ac-LME-tet does not affect the physiological function of peripheral Aβ as a regulator of insulin secretion, further emphasizing the advantage of Ac-LME-tet for use as an effective therapeutic compound for AD treatment.